20 September 2023>: Clinical Research
Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II–III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy
Radu Valeriu Toma 12ABCG , Zgura Anca 1E , Oana Gabriela Trifănescu 12A , Laurenţia Nicoleta Galeş 12D* , Antonia Ruxandra Folea 2CDEF , Loredana Stanca 3B , Liviu Bîlteanu 234ABCDEF* , Rodica M. Anghel 1ADOI: 10.12659/MSM.941754
Med Sci Monit 2023; 29:e941754
Figure 6 The association of changes in echocardiographic semiology with the decrease in EF ≥10% (as a predictor) during monitoring, with treatment modalities, and with the pre-existence of some comorbidities (cardiac preconditioning). The 95% confidence intervals are plotted in a logarithmic scale (from 1 to 1000) for OR and (from 1 to 10) for RR. TT is targeted therapy, ie, anti-HER2 therapy.